Pfizer 2nd dose vaccine 95% effective

Representational Photo

Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their two-dose coronavirus vaccine candidate is 95 percent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus.

The company said that no serious side effects have shown up. The most common complaint was fatigue after the second vaccine dose, affecting about 4 per cent of the participants who got the shot.